Showing results (481-490 of 2,509) with videos related to

Sort By:
Pageof 251
Clinical Lymphoma, Myeloma & Leukemia|February 16, 2023
SOHO State of the Art Updates and Next Questions: Novel Therapeutic Strategies in Development for MyelofibrosisHelen T Chifotides, Lucia Masarova, Srdan Verstovsek
Clinical Lymphoma, Myeloma & Leukemia|May 8, 2021
A Systematic Review and Network Meta-analysis of Randomized Data on Efficacy of Novel Therapy Combinations in Patients with Lenalidomide-refractory Multiple MyelomaGhulam Rehman Mohyuddin, Jill Hampton, Muhammad Aziz, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 20, 2021
The Pattern of Use of PET/CT Scans in the Clinical Management of Chronic Lymphocytic LeukemiaKeren Hod, Yonina Tova, Oded Gold, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 30, 2021
Types, Clinical Features, and Survival Outcomes of Patients with Acute Myeloid Leukemia in Thailand: A 3-Year Prospective Multicenter Study from the Thai Acute Leukemia Study Group (TALSG)Chinadol Wanitpongpun, Eakkapol Utchariyaprasit, Weerapat Owattanapanich, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 10, 2020
A Multi-Institutional Validation of the Prognostic Value of the Neutrophil-to-Lymphocyte Ratio in Patients With Diffuse Large B-Cell Lymphoma: A Study From The Latin American Group of Lymphoproliferative Disorders (GELL)Brady E Beltrán, Luis Villela, Maria A Torres, et al.
Clinical Lymphoma, Myeloma & Leukemia|May 23, 2020
No Differences in Outcomes Between JAK2 V617F-Positive Patients with Variant Allele Fraction < 2% Versus 2-10%: A 6-Year Province-wide Retrospective AnalysisWasithep Limvorapitak, Jeremy Parker, Curtis Hughesman, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 13, 2021
Real-World Characteristics and Outcome of Patients Treated With Single-Agent Ibrutinib for Chronic Lymphocytic Leukemia in Spain (IBRORS-LLC Study)Pau Abrisqueta, Javier Loscertales, Maria José Terol, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 21, 2021
The Effects of Exercise Prescription on Aerobic Performance and Quality of Life During the Course of Lymphoma Chemotherapy: Results of a Prospective Controlled StudyUgur Sahin, Ibrahim Dundar, Mehmet Mesut Celebi, et al.
Clinical Lymphoma, Myeloma & Leukemia|August 31, 2021
Late Responses in Patients With Chronic Myeloid Leukemia Initially Refractory to Tyrosine Kinase InhibitorsJustin Shaya, Kristen Pettit, Malathi Kandarpa, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 27, 2023
Augmented ICE in Patients With Poor-Risk Refractory and Relapsed LymphomasSun Loo, Andrew Lim, Sze Ting Lee, et al.
Pageof 251